As­traZeneca and GSK set­tle tal­ent feud in court — again

As­traZeneca and GSK have set­tled their lat­est tal­ent skir­mish, clear­ing the way for 18-plus-year As­traZeneca vet­er­an Chris Shel­don to start a new gig at the ri­val phar­ma next month.

Shel­don and GSK con­firmed the news to End­points News on Tues­day, more than a month af­ter As­traZeneca was grant­ed an in­junc­tion to stop him from start­ing at GSK as the next se­nior VP of its com­mer­cial port­fo­lio, mul­ti­ple sources in­clud­ing the Fi­nan­cial Times re­port­ed in Au­gust.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER